Literature DB >> 6584668

Natural history of body weight gain, survival, and neoplasia in the F344 rat.

H A Solleveld, J K Haseman, E E McConnell.   

Abstract

This study involved the fact that knowledge of the natural incidence of neoplastic lesions is essential for interpretation of experiments designed to reveal the effects of potential carcinogens. Although the F344 rat is widely used in chronic (2-yr) testing programs, the natural history of neoplasia after 24 months is not known; thus this study, with 529 male and 529 female inbred F344 rats, was designed to deal with this aspect. This report also included information on growth and longevity. In addition, the tumor rates found in this study were compared with 2-year historic control tumor rates; results revealed the following. 1) Maximum mean body weights were 468 and 330 g for males and females, respectively. Peak weight in males was reached at 77 weeks of age and in females, at 107 weeks of age. 2) There was no clear sex difference in longevity; a median life-span (50% survival age) or 28 months was recorded in both sexes. 3) Variety of neoplastic lesions in animals that were allowed to live out their life-span was not greater than that in animals that were killed between 110 and 116 weeks of age; thus older age was not characterized by unique neoplasms. 4) The incidence of certain neoplasms increased markedly after 110-116 weeks. The data indicated that life-span studies in F344 rats had no advantages over 2-year studies. However, availability of life-span data is essential for interpretation of the 2-year studies.

Entities:  

Mesh:

Year:  1984        PMID: 6584668

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  33 in total

1.  DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES.

Authors:  Ronald L Melnick; John R Bucher
Journal:  J Law Policy       Date:  2005

2.  Experimental studies with palygorskite dusts.

Authors:  J C Wagner; D M Griffiths; D E Munday
Journal:  Br J Ind Med       Date:  1987-11

3.  Spontaneous uterine adenocarcinomas in aged rats and their relation to endocrine imbalance.

Authors:  T Nagaoka; H Onodera; Y Matsushima; A Todate; M Shibutani; H Ogasawara; A Maekawa
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract.

Authors:  Gregory J Brewer; John R Torricelli; Amanda L Lindsey; Elizabeth Z Kunz; A Neuman; Derek R Fisher; James A Joseph
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

5.  Lewis rats of the inbred strain LEW/Han: life expectancy, spectrum and incidence of spontaneous neoplasms.

Authors:  A Baum; G Pohlmeyer; K G Rapp; F Deerberg
Journal:  Exp Toxicol Pathol       Date:  1995-01

6.  Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons.

Authors:  Jigisha R Patel; Gregory J Brewer
Journal:  Exp Neurol       Date:  2008-05-22       Impact factor: 5.330

7.  On the stability of DNA in photoreceptor cells of rat retina.

Authors:  T Ishikawa
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

8.  Age-Related Hearing Loss Is Dominated by Damage to Inner Ear Sensory Cells, Not the Cellular Battery That Powers Them.

Authors:  Pei-Zhe Wu; Jennifer T O'Malley; Victor de Gruttola; M Charles Liberman
Journal:  J Neurosci       Date:  2020-07-20       Impact factor: 6.167

9.  Age-related changes to tumor necrosis factor receptors affect neuron survival in the presence of beta-amyloid.

Authors:  Jigisha R Patel; Gregory J Brewer
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

10.  Critical age-related loss of cofactors of neuron cytochrome C oxidase reversed by estrogen.

Authors:  Torrie T Jones; Gregory J Brewer
Journal:  Exp Neurol       Date:  2008-09-30       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.